Sickle cell disease is a genetic blood disorder caused by a single mutation in both copies of a gene coding for beta-globin. Beta-globin forms half of the oxygen-carrying molecule hemoglobin.
Last May, a 12-year-old with sickle cell anemia was the first person to receive a new gene therapy to treat the disease. The process is painful, expensive, and still frightening and uncertain ...
Sickle cell disease is an inherited genetic condition, explained Dr. Férol Gbénou. It is characterized by abnormal hemoglobin, which can block blood flow and cause pain and organ damage.
Vertex and CRISPR Therapeutics have won the backing of NICE for their gene-editing therapy Casgevy ... a few months after turning it down for sickle cell disease. Final draft guidance published ...